Human Phospho-Ubiquitin (S65) Antibody
R&D Systems, part of Bio-Techne | Catalog # A-110
Product is in the process of being discontinued.

Discontinued Product
A-110 has been discontinued.
View all Ubiquitin products.
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Product Specifications
Immunogen
Peptide sequence from Ubiquitin, phosphorylated at Serine 65.
Accession # P0CG47
Accession # P0CG47
Specificity
This antibody detects mono- and poly-Ubiquitin chains that are phosphorylated on Serine 65. It has no cross-reactivity with non-phosphorylated Ubiquitin, Ubiquitin phosphorylated at Serine 57 or Tyrosine 59, or phosphorylated Parkin. Detects only recombinant, phosporylated Ubiquitin. Not recommended on natural lysates (see western blot results below).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Human Phospho-Ubiquitin (S65) Antibody
Detection of Phospho-Ubiquitin (S65) by Western blot.
Tetraubiquitin chains of each indicated linkage type were incubated for 0-4 hours in reactions containing recombinant PINK1 kinase (Cat# AP-180) and ATP. At indicated times a portion of each reaction was removed and terminated with SDS-PAGE sample buffer. SDS-PAGE gels (10-20%) were used to resolve approximately 150 ng of Ubiquitin tetramer from each reaction. Western Blots were developed using either alpha-phospho-Ubiquitin, pS65 (upper panels) or anti-Ubiquitin (Cat# MAB701, lower panel). Primary antibodies were used at 1 μg/ml in PBST + 0.5% BSA, while HRP-labeled secondary antibodies ( alpha-rabbit for A-110, alpha-mouse for MAB701) were used at a 1:10,000 dilution in PBST + 0.5% BSA. Further details are available upon request.Detection of Phospho-Ubiquitin (S65) by Western blot.
Tetraubiquitin chains of each indicated linkage type were incubated for 0-4 hours in reactions containing recombinant PINK1 kinase (Cat# AP-180) and ATP. At indicated times a portion of each reaction was removed and terminated with SDS-PAGE sample buffer. SDS-PAGE gels (10-20%) were used to resolve approximately 150 ng of Ubiquitin tetramer from each reaction. Western Blots were developed using either alpha-phospho-Ubiquitin, pS65 (upper panels) or anti-Ubiquitin (Cat# MAB701, lower panel). Primary antibodies were used at 1 μg/ml in PBST + 0.5% BSA, while HRP-labeled secondary antibodies ( alpha-rabbit for A-110, alpha-mouse for MAB701) were used at a 1:10,000 dilution in PBST + 0.5% BSA. Further details are available upon request.Applications for Human Phospho-Ubiquitin (S65) Antibody
Application
Recommended Usage
Western Blot
0.5-1 µg/mL
Sample: Only recommended on recombinant Ubiquitin chains
Sample: Only recommended on recombinant Ubiquitin chains
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
0.5 mg/ml in PBS pH 7.4, 50% (v/v) Glycerol
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20°C. Storage at -80°C is not recommended.
Background: Ubiquitin
Additional Ubiquitin Products
Product Documents for Human Phospho-Ubiquitin (S65) Antibody
Product Specific Notices for Human Phospho-Ubiquitin (S65) Antibody
For research use only
Loading...
Loading...
Loading...